Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4489-4493

  Schreiner, Felix ^a   Stutte, Sonja ^a   Bartmann, Peter ^a   Gohlke, Bettina ^a   Woelfle, Joachim ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RECEPTOR D3; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BIRTH WEIGHT; CATCH UP GROWTH; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; POSTNATAL GROWTH; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VERY LOW BIRTH WEIGHT;

EID: 35949002784     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0956     Document Type: Article

References (36)

1. Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawaski E 2003 Growth of very low birth weight infants to age 20 years. Pediatrics 112(1 Pt 1):e30-e38
2. Knops NB, Sneeuw KC, Brand R, Hille ET, den Ouden AL, Wit JM, Verloove-Vanhorick SP 2005 Catch-up growth up to ten years of age in children born very preterm or with very low birth weight. BMC Pediatr 5:26
3. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
4. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ 2006 Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076-1080
5. Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659-664
6. Pilotta A, Mella P, Filisetti M, Felappi B, Prandi E, Parrinello G, Notarangelo LD, Buzi F 2006 Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 91:1178-1180
7. Carrascosa A, Esteban C, Espadero R, Fernandez-Cancio M, Andaluz P, Clemente M, Audi L, Wollmann H, Fryklund L, Parodi L, and the Spanish SGA Study Group 2006 The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 μg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective Study in 170 Spanish patients. J Clin Endocrinol Metab 91:3281-3286
8. Blum WF, Machinis K, Shavrikova EP, Keller A, Stobbe H, Pfaeffle RW, Amselem S 2006 The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. J Clin Endocrinol Metab 91:4171-4174
9. Hermanussen M, Thiel C, Tscharntke V, von Büren E 1999 Synthetische Referenzwerte für Körpergröße. Deutsche Normalwerte (Basis 1993) für alle Altersstufen zwischen 0 und 20 Jahren. Kinder Jugendarzt 30:488-493
10. Voigt M, Schneider KT, Jahrig K 1992 Analysis of a 1992 birth sample in Germany: new percentile values of the body weight of newborn infants. Geburtshilfe Frauenheilkd 56:550-558 (German)
11. Walsh P, Metzger DA, Higuchi R 1991 Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10:506-513
12. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goosens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
13. Audi L, Esteban C, Carrascosa A, Espadero R, Perez-Arroyo A, Arjona R, Clemente M, Wollmann H, Fryklund L, Parodi LA, and the Spanish SGA Study Group 2006 Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA. J Clin Endocrinol Metab 91:5038-5043
14. Blum W, Schweizer R 2003 Insulin-like growth factors and their binding proteins. In: Ranke MB, ed. Diagnostics of endocrine function in children and adolescents. 3rd ed. Basel: Karger; 166-200
15. Brandt I, Sticker EJ, Gausche R, Lentze MJ 2005 Catch-up growth of supine length/height of very low birth weight, small for gestational age preterm infants to adulthood. J Pediatr 147:662-668
16. Kenth G, Shao Z, Cole DE, Goodyer CG 2007 Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. J Clin Endocrinol Metab 92:725-728
17. Mericq V, Roman R, Iniguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F 2007 Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children. Horm Res 68:132-138
18. Regan FM, Cutfield WS, Jefferies C, Robinson E, Hofman PL 2006 The impact of early nutrition in premature infants on later childhood insulin sensitivity and growth. Pediatrics 118:1943-1949
19. Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS 2004 Premature birth and later insulin resistance. N Engl J Med 351:2179-2186
20. Bazaes RA, Alegria A, Pittaluga E, Avila A, Iniguez G, Mericq V 2004 Determinants of insulin sensitivity and secretion in very-low-birth-weight children. J Clin Endocrinol Metab 89:1267-1272
21. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ 1989 Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580
22. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD 1991 Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019-1022
23. Cianfarani S, Germani D, Branca F 1999 Low birth weight and adult insulin resistance: the "catch-up growth" hypothesis. Arch Dis Child Fetal Neonatal Ed 81:F71-F73
24. Cianfarani S 2003 Foetal origins of adult diseases: just a matter of stem cell number? Med Hypotheses 61:401-404
25. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD 1997 Insulin resistance in short children with intrauterine growth restriction. J Clin Endocrinol Metab 82:402-406
26. Iniguez G, Ong K, Bazaes R, Avila A, Salazar T, Dunger D, Mericq V 2006 Longitudinal changes in insulin-like growth factor-I, insulin-sensitivity, and secretion from birth to age three years in small-for-gestational-age children. J Clin Endocrinol Metab 91:4645-4649
27. Cutfield WS, Hofman PL, Mitchell M, Morison IM 2007 Could epigenetics play a role in the developmental origins of health and disease? Pediatr Res 61(5 Pt 2):68R-75R
28. Leger J, Noel M, Limal JM, Czernichow P 1996 Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res 40:101-107
29. Kajantie E, Dunkel L, Rutanen EM, Seppala M, Koistinen R, Sarnesto A, Andersson S 2002 IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab 87:2171-2179
30. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ 2002 Circulating concentrations of insulin-like growth factor-1 and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745
31. Kajantie E, Fall CH, Seppala M, Koistinen R, Dunkel L, Yliharsila H, Osmond C, Andersson S, Barker DJ, Forsen T, Holt RI, Phillips DI, Eriksson J 2003 Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth. J Clin Endocrinol Metab 88:1059-1065
32. Gluckman PD, Sizonenko SV, Bassett NS 1999 The transition from fetus to neonate: an endocrine perspective. Acta Paediatr Suppl 88:7-11
33. Woelfle J, Chia DJ, Massart-Schlesinger MB, Moyano P, Rotwein P 2005 Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system. Pediatr Nephrol 20:295-302
34. Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D 2005 Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm IGF Res 15:324-336
35. Kratzsch J, Wu Z, Kiess W, Dehmel B, Bosse-Henck A, Reuter W, Pflaum CD, Strasburger CJ 2001 The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently. Clin Endocrinol (Oxf) 54:61-68
36. Seidel B, Glasow A, Schutt M, Kiess W, Wu Z, Strasburger CJ, Kratzsch J 2003 Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum. Eur J Endocrinol 148:317-324